Proto Labs, Inc.
US ˙ NYSE ˙ US7437131094

Introduction

This page provides a comprehensive analysis of the known insider trading history of John Way. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate John Way has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:PRLB / Proto Labs, Inc. Chief Financial Officer 3,128
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by John Way. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases PRLB / Proto Labs, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in PRLB / Proto Labs, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PRLB / Proto Labs, Inc. Insider Trades
Insider Sales PRLB / Proto Labs, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in PRLB / Proto Labs, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2020-08-06 PRLB WAY JOHN 13,701 131.4379 13,701 131.4379 1,800,831 357 77.77 -735,303 -40.83
2020-08-06 PRLB WAY JOHN 2,050 132.5285 2,050 132.5285 271,683
2020-08-06 PRLB WAY JOHN 200 133.6550 200 133.6550 26,731
2018-08-24 PRLB WAY JOHN 2,426 145.5090 2,426 145.5090 353,005
2018-08-24 PRLB WAY JOHN 1,486 146.2531 1,486 146.2531 217,332

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PRLB / Proto Labs, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by John Way as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2021-02-18 2021-02-16 4 PRLB Proto Labs Inc
Employee Stock Option (right to buy)
A - Award 3,128 3,128
2021-02-18 2021-02-16 4 PRLB Proto Labs Inc
Common Stock
A - Award 4,433 33,657 15.17
2021-02-18 2021-02-16 4 PRLB Proto Labs Inc
Common Stock
F - Taxes -2,171 29,224 -6.92 197.05 -427,796 5,758,589
2020-08-10 2020-08-06 4 PRLB Proto Labs Inc
Employee Stock Option (right to buy)
M - Exercise -2,608 0 -100.00
2020-08-10 2020-08-06 4 PRLB Proto Labs Inc
Employee Stock Option (right to buy)
M - Exercise -8,348 2,837 -74.64
2020-08-10 2020-08-06 4 PRLB Proto Labs Inc
Employee Stock Option (right to buy)
M - Exercise -4,995 0 -100.00
2020-08-10 2020-08-06 4 PRLB Proto Labs Inc
Common Stock
S - Sale -200 31,150 -0.64 133.66 -26,731 4,163,353
2020-08-10 2020-08-06 4 PRLB Proto Labs Inc
Common Stock
S - Sale -2,050 31,350 -6.14 132.53 -271,683 4,154,768
2020-08-10 2020-08-06 4 PRLB Proto Labs Inc
Common Stock
S - Sale -13,701 33,400 -29.09 131.44 -1,800,831 4,390,026
2020-08-10 2020-08-06 4 PRLB Proto Labs Inc
Common Stock
M - Exercise 2,608 47,101 5.86 62.90 164,043 2,962,653
2020-08-10 2020-08-06 4 PRLB Proto Labs Inc
Common Stock
M - Exercise 8,348 44,493 23.10 57.88 483,182 2,575,255
2020-08-10 2020-08-06 4 PRLB Proto Labs Inc
Common Stock
M - Exercise 4,995 36,145 16.04 67.15 335,414 2,427,137
2020-02-18 2020-02-13 4 PRLB Proto Labs Inc
Common Stock
F - Taxes -1,756 31,150 -5.34 100.00 -175,600 3,115,000
2020-02-12 2020-02-10 4 PRLB Proto Labs Inc
Employee Stock Option (right to buy)
A - Award 5,501 5,501
2020-02-12 2020-02-10 4 PRLB Proto Labs Inc
Common Stock
A - Award 4,607 32,906 16.28
2019-12-03 2019-12-01 4 PRLB Proto Labs Inc
Common Stock
F - Taxes -195 28,299 -0.68 95.83 -18,687 2,711,893
2019-02-15 2019-02-13 4 PRLB Proto Labs Inc
Common Stock
F - Taxes -1,435 28,021 -4.87 108.47 -155,654 3,039,438
2019-02-13 2019-02-11 4 PRLB Proto Labs Inc
Employee Stock Option (right to buy)
A - Award 4,806 4,806
2019-02-13 2019-02-11 4 PRLB Proto Labs Inc
Common Stock
A - Award 4,244 29,456 16.83
2018-12-19 2018-12-01 4 PRLB Proto Labs Inc
Common Stock
F - Taxes -291 25,212 -1.14 126.93 -36,937 3,200,159
2018-09-26 2018-09-24 4 PRLB Proto Labs Inc
Employee Stock Option (right to buy)
M - Exercise X -3,000 11,185 -21.15
2018-09-26 2018-09-24 4 PRLB Proto Labs Inc
Employee Stock Option (right to buy)
M - Exercise X -5,000 4,995 -50.03
2018-09-26 2018-09-24 4 PRLB Proto Labs Inc
Common Stock
S - Sale X -4,644 25,503 -15.40 160.14 -743,692 4,084,058
2018-09-26 2018-09-24 4 PRLB Proto Labs Inc
Common Stock
S - Sale X -3,356 30,147 -10.02 157.66 -529,105 4,752,955
2018-09-26 2018-09-24 4 PRLB Proto Labs Inc
Common Stock
M - Exercise X 3,000 33,503 9.84 57.88 173,640 1,939,154
2018-09-26 2018-09-24 4 PRLB Proto Labs Inc
Common Stock
M - Exercise X 5,000 30,503 19.61 67.15 335,750 2,048,276
2018-08-28 2018-08-24 4 PRLB Proto Labs Inc
Employee Stock Option (right to buy)
M - Exercise -3,912 2,608 -60.00
2018-08-28 2018-08-24 4 PRLB Proto Labs Inc
Common Stock
S - Sale -1,486 25,503 -5.51 146.25 -217,332 3,729,893
2018-08-28 2018-08-24 4 PRLB Proto Labs Inc
Common Stock
S - Sale -2,426 26,989 -8.25 145.51 -353,005 3,927,142
2018-08-28 2018-08-24 4 PRLB Proto Labs Inc
Common Stock
M - Exercise 3,912 29,415 15.34 62.90 246,065 1,850,204
2018-02-21 2017-12-01 4 PRLB Proto Labs Inc
Common Stock
F - Taxes -214 25,503 -0.83 103.00 -22,042 2,626,809
2018-02-16 2018-02-13 4 PRLB Proto Labs Inc
Common Stock
F - Taxes -1,148 25,717 -4.27 106.45 -122,205 2,737,575
2018-02-14 2018-02-12 4 PRLB Proto Labs Inc
Employee Stock Option (right to buy)
A - Award 4,291 4,291
2018-02-14 2018-02-12 4 PRLB Proto Labs Inc
Common Stock
A - Award 3,745 26,865 16.20 105.75 396,034 2,840,974
2017-02-15 2017-02-13 4 PRLB Proto Labs Inc
Employee Stock Option (right to buy)
A - Award 6,805 6,805
2017-02-15 2017-02-13 4 PRLB Proto Labs Inc
Common Stock
A - Award 9,645 22,675 74.02 58.35 562,786 1,323,086
2016-02-11 2016-02-08 4/A PRLB Proto Labs Inc
Employee Stock Option (right to buy)
A - Award 14,185 14,185
2016-02-10 2016-02-08 4 PRLB Proto Labs Inc
Employee Stock Option (right to buy)
A - Award 14,185 14,185
2016-02-10 2016-02-08 4 PRLB Proto Labs Inc
Common Stock
A - Award 6,480 12,626 105.43 57.88 375,062 730,793
2015-02-11 2015-02-09 4 PRLB Proto Labs Inc
Employee Stock Option (right to buy)
A - Award 9,995 9,995
2015-02-11 2015-02-09 4 PRLB Proto Labs Inc
Common Stock
A - Award 2,610 5,790 82.08
2014-12-03 2014-12-01 4 PRLB Proto Labs Inc
Employee Stock Option (right to buy)
A - Award 6,520 6,520
2014-12-03 2014-12-01 4 PRLB Proto Labs Inc
Common Stock
A - Award 3,180 3,180
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)